Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study
BMC Gastroenterology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: July 18, 2024
Abstract
Objectives
To
determine
how
fetuin-A
contributes
to
diagnosing
and
assessing
MASLD
severity.
Methods
Fifty
patients
fifty
healthy
control
participants
were
involved
in
this
retrospective
case-control
research.
Abdominal
ultrasonography,
fibroscan
with
controlled
attenuated
parameter
scan
(CAP
scan),
laboratory
investigation
(including
assessment),
clinical
examination,
history-taking
performed
on
every
case.
Results
Fetuin-A
level
was
considerably
higher
the
Cases
group
(1154.85
±
629.89)
than
Control
(505.29
150.4)
(
p
<
0.001).
had
significant
validity
prediction
of
at
a
cut-off
>
702.5
82%
sensitivity,
90%
specificity,
86%
overall
accuracy.
Conclusion
One
possible
marker
for
diagnosis
could
be
fetuin-A.
Furthermore,
substantial
association
between
such
severity
disease
as
it
revealed
correlation
ultrasound
grading
parameters.
Trial
registration
1-
Pan
African
Clinical
Registry.
Unique
Identifying
number/registration
ID:
PACTR202309644280965.
URL:
https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=26860
.
Registration
Approval
date:
21/09/2023.
2-
ClinicalTrials.gov
number
/registration
NCT06097039.
https://clinicaltrials.gov/study/NCT06097039?cond=NCT06097039&rank=1
25/10/2023.
Language: Английский
Curcumin inhibits pancreatic steatosis in mice with high fat diet through YAP/P53 pathway and confirmed through ultrasonic imaging
Helin Ke,
No information about this author
Ziwei Xu,
No information about this author
Lina Han
No information about this author
et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids,
Journal Year:
2025,
Volume and Issue:
unknown, P. 159605 - 159605
Published: Feb. 1, 2025
Language: Английский
Performance of Magnetic Resonance Imaging and Ultrasound for Identifying the Different Degrees of Hepatic Steatosis: A Systematic Review and Meta-analysis
Shuzhen Wu,
No information about this author
Junhan Pan,
No information about this author
Mengchen Song
No information about this author
et al.
Academic Radiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
MRI
proton
density
fat
fraction
(MRI-PDFF),
controlled
attenuation
parameters
(CAP),
and
coefficients
(AC)
are
capable
of
steatosis
characterization
may
be
useful
as
noninvasive
alternatives
for
diagnosing
hepatic
steatosis.
This
meta-analysis
aimed
to
evaluate
the
performance
MRI-PDFF,
CAP,
AC
in
grading
steatosis,
using
histology
reference
standard.
We
conducted
a
comprehensive
search
PubMed,
Cochrane
Library,
Embase,
Web
Science
databases
until
June
2024.
The
quality
eligible
studies
was
assessed.
Pooled
sensitivity,
specificity,
area
under
receiver
operating
characteristic
(AUC)
curves
were
calculated
bivariate
random-effects
model.
Meta-regression
analysis,
subgroup
Deeks'
test
performed
explore
heterogeneity
assess
publication
bias.
included
38
with
5056
patients
metabolic
dysfunction-associated
steatotic
liver
disease.
AUC
values
≥S1,
≥S2,
≥S3
0.99,
0.89,
0.90
0.95,
0.84,
0.77
0.97,
0.90,
0.89
AC,
respectively.
CAP
demonstrated
lower
accuracy
detecting
grades
≥S2
compared
MRI-PDFF
(0.89
vs.
p<0.001;
0.77,
p<0.001)
(0.90
p<0.001).
Subgroup
analyses
revealed
that
exhibited
superior
diagnostic
among
individuals
Asia,
body
mass
index
≤30
kg/m2,
age
<51
years.
A
direct
comparison
showed
greater
moderate
severe
similar
AC.
For
should
incorporated
into
routine
ultrasound
screening.
Language: Английский